The ACE inhibitor ramipril was used as a reference agent. Patients and Methods: A group of 104 adult patients with arterial hypertension and respiratory disorders took part in a double-blind ...
The Heart Outcomes Prevention Evaluation (HOPE) study was a landmark study employing the angiotensin-converting enzyme (ACE) inhibitor ramipril in a patient population predestined for vascular events.